Items where the Publication is Journal of neurology, neurosurgery, and psychiatry

Year Authors/Creators Item Type Full Text

Bibliographic data only

MUTANT HUNTINGTIN FRAGMENTATION IN IMMUNE CELLS TRACKS HUNTINGTON'S DISEASE PROGRESSION. (2012) Andre, R; Weiss, A; Trager, U; Grueninger, S; Farmer, R; Landles, C; Scahill, R; Lahiri, N; Haider, S; MacDonald, D; Frost, C; Bates, G; Bilbe, G; Kuhn, R; Wild, E; Tabrizi, SJ

Quality of life in dementia: more than just cognition. An analysis of associations with quality of life in dementia. (2006) Banerjee, S; Smith, SC; Lamping, DL; Harwood, RH; Foley, B; Smith, P; Murray, J; Prince, M; Levin, E; Mann, A; Knapp, M

Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis. (2006) Bieniek, M; Altmann, DR; Davies, GR; Ingle, GT; Rashid, W; Sastre-Garriga, J; Thompson, AJ; Miller, DH

Cervical cord and brain grey matter atrophy independently associate with long-term MS disability. (2010) Bonati, U; Fisniku, LK; Altmann, DR; Yiannakas, MC; Furby, J; Thompson, AJ; Miller, DH; Chard, DT

International co-operative ataxia rating scale (ICARS): Suitable for clinical practice and treatment trials in Friedreich's ataxia? (2006) Cano, SJ; Hobart, JC; Hart, PE; Kolipara, LVP; Schapira, AHV; Cooper, JM

The Friedreich's Ataxia impact scale (FAIS) meets the needs of today's clinical studies. (2006) Cano, SJ; Riazi, A; Cooper, JM; Schapira, AHV; Hobart, JC

Disability, distress and unemployment in neurology outpatients with symptoms 'unexplained by organic disease'. (2011) Carson, A; Stone, J; Hibberd, C; Murray, G; Duncan, R; Coleman, R; Warlow, C; Roberts, R; Pelosi, A; Cavanagh, J; Matthews, K; Goldbeck, R; Hansen, C; Sharpe, M

Somatic symptom count scores do not identify patients with symptoms unexplained by disease: a prospective cohort study of neurology outpatients. (2014) Carson, Alan J; Stone, Jon; Hansen, Christian Holm; Duncan, Rod; Cavanagh, Jonathon; Matthews, Keith; Murray, G; Sharpe, Michael

The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: a 14 year follow up study. (2003) Chard, DT; Brex, PA; Ciccarelli, O; Griffin, CM; Parker, GJM; Dalton, C; Altmann, DR; Thompson, AJ; Miller, DH

COGNITIVE AND NEUROPSYCHIATRIC STATUS IN A LARGE COHORT OF PATIENTS WITH SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS The combined influence of parental education and preterm birth on school performance. (2011) Chataway, J; Awad, M; Meadmore, K; Alsanousi, A; Frost, C; Chandler, K; Merrick, K; Wilkie, D; Nicholas, R; Chan, D; Gisselmann, M; Koupil, I; de Stavola, BL

Long term risks of stroke, myocardial infarction, and vascular death in "low risk" patients with a non-recent transient ischaemic attack. (2003) Clark, TG; Murphy, MFG; Rothwell, PM

RELIABILITY OF DIFFUSION TENSOR IMAGING MEASURES. (2012) Cole, J; Rees, EM; Farmer, RE; Crawford, HE; Mueller, HP; Sprengelmeyer, R; Frost, C; Durr, A; Landwehrmeyer, B; Tabrizi, SJ; Scahill, RI; Hobbs, NZ

T cell recognition of a non-protein antigen preparation of Campylobacter jejuni in patients with Guillain-Barré syndrome. (2002) Cooper, JC; Hughes, S; Ben-Smith, A; Savage, COS; Winer, JB

CORPUS CALLOSAL ATROPHY IN HUNTINGTON'S DISEASE. (2012) Crawford, HE; Hobbs, NZ; Cole, J; Rees, EM; Owen, G; Langbehn, DR; Frost, C; Landwehrmeyer, B; Reilmann, R; Craufurd, D; Stout, JC; Durr, A; Leavitt, B; Roos, RA; Tabrizi, SJ; Scahill, RI; Investigators, Track-, Hd

Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes. (2010) Di Filippo, M; Anderson, VM; Altmann, DR; Swanton, JK; Plant, GT; Thompson, AJ; Miller, DH

Disability and T2 MRI abnormalities: A 20 year follow-up of patients with relapse onset of multiple sclerosis. (2007) Fisniku, LK; Brex, PA; Miszkiel, K; Altmann, DR; Thompson, AJ; Miller, DH

Why, for once, is the UK leading the way in implementing evidence? (2013) Fraser, Alec; Rudd, Anthony

THE POTENTIAL OF A COMPOSITE COGNITIVE SCORE FOR TRACKING PROGRESSION IN HUNTINGTON'S DISEASE. (2012) Frost, C; Jones, R; Labuschange, I; Say, M; Justo, D; Coleman, A; Dumas, E; T Hart, E; Owen, G; Durr, A; Leavitt, B; Roos, R; O'Regan, A; Tabrizi, SJ; Stout, JC

Brain microbleeds as a potential risk factor for antiplatelet-related intracerebral haemorrhage: hospital-based, case-control study. (2010) Gregoire, SM; Jäger, HR; Yousry, TA; Kallis, C; Brown, MM; Werring, DJ

SIRT 1 MEDIATED MODULATION OF CIRCULATING CYTOKINES IN HUNTINGTON'S DISEASE-PHARMACODYNAMICS RESULTS FROM PHASE 1B STUDY OF SELISISTAT-A SIRT 1 INHIBITOR. (2012) Haider, S; Andre, R; Farmer, R; Sussmuth, S; Frost, C; Bjorkqvist, M; Westerberg, G; Landwehrmeyer, B; Tabrizi, SJ; Consortium, Paddington

FROM BIOLOGY TO THE BEDSIDE-SIRTUINS AS TARGETS FOR DISEASE MODIFICATION IN HUNTINGTON'S DISEASE: SELISISTAT PRECLINICAL DATA AND PRELIMINARY PHASE I RESULTS. (2012) Haider, SS; Landwehrmeyer, BG; Sissumuth, SD; Frost, C; Farmer, R; Andre, R; Caricasole, A; Crauford, DI; Westerberg, G; Tabrizi, SJ

Tau gene and Parkinson's disease: a case-control study and meta-analysis. (2004) Healy, DG; Abou-Sleiman, PM; Lees, AJ; Casas, JP; Quinn, N; Bhatia, K; Hingorani, AD; Wood, NW

An investigation of the retinal nerve fibre layer in progressive multiple sclerosis. (2008) Henderson, APD; Trip, SA; Schlottmann, PG; Altmann, DR; Garway-Heath, DF; Plant, GT; Miller, DH

MRI and cognitive changes detectable over 6 and 12 months in early Huntington's disease. (2005) Henley, SMD; Warrington, EK; Frost, C; MacManus, DG; Warner, TT; Fox, NC; Tabrizi, SJ

Corticosteroids do not prevent optic nerve atrophy following optic neuritis. (2003) Hickman, SJ; Kapoor, R; Jones, SJ; Altmann, DR; Plant, GT; Miller, DH

The SF-36 in multiple sclerosis: why basic assumptions must be tested. (2001) Hobart, J; Freeman, J; Lamping, D; Fitzpatrick, R; Thompson, A

How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales. (2005) Hobart, JC; Riazi, A; Lamping, DL; Fitzpatrick, R; Thompson, AJ

EVALUATION OF MULTI-MODAL, MULTI-SITE IMAGING MEASURES IN HUNTINGTON'S DISEASE: BASELINE RESULTS FROM THE PADDINGTON STUDY. (2012) Hobbs, NZ; Cole, J; Farmer, RE; Rees, EM; Scahill, RI; Crawford, HE; Roos, RAC; Sprengelmeyer, R; Durr, A; Landwehrmeyer, B; Tabrizi, SJ; Frost, C

Short-interval observational data to inform clinical trial design in Huntington's disease. (2015) Hobbs, Nicola Z; Farmer, Ruth E; Rees, Elin M; Cole, James H; Haider, Salman; Malone, Ian B; Sprengelmeyer, Reiner; Johnson, Hans; Mueller, Hans-Peter; Sussmuth, Sigurd D; Roos, Raymund AC; Durr, Alexandra; Frost, Chris; Scahill, Rachael I; Landwehrmeyer, Bernhard; Tabrizi, Sarah J

Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. (2004) Katzenschlager, R; Evans, A; Manson, A; Patsalos, PN; Ratnaraj, N; Watt, H; Timmermann, L; Van der Giessen, R; Lees, AJ

Low dose quetiapine for drug induced dyskinesias in Parkinson's disease: a double blind cross over study. (2004) Katzenschlager, R; Manson, AJ; Evans, A; Watt, H; Lees, AJ

Olfactory function distinguishes vascular parkinsonism from Parkinson's disease. (2004) Katzenschlager, R; Zijlmans, J; Evans, A; Watt, H; Lees, AJ

Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis. (2014) Kearney, H; Schneider, T; Yiannakas, MC; Altmann, DR; Wheeler-Kingshott, CAM; Ciccarelli, O; Miller, DH

Aciclovir induced posterior leucoencephalopathy. (2005) Mahad, DJ; Helldén, A; Jarvis, J; Mitra, D; Gholkar, A; Chinnery, PF

LONGITUDINAL DIFFUSION TENSOR IMAGING IN THE PRIMARY PROGRESSIVE APHASIAS. (2018) Mahoney, CJ; Simpson, IJA; Nicholas, JM; Rohrer, JD; Warren, JD

Increased platelet count and leucocyte-platelet complex formation in acute symptomatic compared with asymptomatic severe carotid stenosis. (2005) McCabe, DJH; Harrison, P; Mackie, IJ; Sidhu, PS; Purdy, G; Lawrie, AS; Watt, H; Machin, SJ; Brown, MM

High Prevalence of Distal Sensory Polyneuropathy in Treated and Untreated Tanzanians with HIV. A Cross-Sectional Survey. (2010) Mullin, S; Temu, A; Kalluvya, S; Grant, A; Manji, H

The corpus callosum in first episode schizophrenia: a diffusion tensor imaging study. (2005) Price, G; Bagary, MS; Cercignani, M; Altmann, DR; Ron, MA

Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study. (2006) Rashid, W; Davies, GR; Chard, DT; Griffin, CM; Altmann, DR; Gordon, R; Thompson, AJ; Miller, DH

Abnormalities of cerebral perfusion in multiple sclerosis. (2004) Rashid, W; Parkes, LM; Ingle, GT; Chard, DT; Toosy, AT; Altmann, DR; Symms, MR; Tofts, PS; Thompson, AJ; Miller, DH

EVALUATION OF LIFE TIME PHYSICAL ACTIVITY LEVELS IN HUNTINGTON'S DISEASE. (2012) Read, J; Owen, G; Keogh, R; Busse, M; Jauffret, C; Coleman, A; T Hart, E; Borrowsky, B; Tabrizi, SJ; Investigators, Track-, Hd

COGNITIVE FUNCTIONS OF THE PUTAMEN IN HUNTINGTON'S DISEASE. (2012) Rees, EM; Hobbs, NZ; Farmer, RE; Henley, SMD; Haider, S; Scahill, RI; Tabrizi, SJ

Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles. (2003) Riazi, A; Hobart, JC; Lamping, DL; Fitzpatrick, R; Freeman, JA; Jenkinson, C; Peto, V; Thompson, AJ

Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. (2002) Riazi, A; Hobart, JC; Lamping, DL; Fitzpatrick, R; Thompson, AJ

Assessing the risk of subsequent tonic-clonic seizures in patients with a history of simple or complex partial seizures. (2012) Rogers, Jennifer K; Hutton, Jane; Marson, Anthony G; Chadwick, David W

Genetics of ischaemic stroke in ethnic minorities. (2007) Sharma, P; Whittaker, J; Casas, JP; Hingorani, AD; Ariyaratnam, R

Track-HD tracking progression in premanifest and early Huntington's disease. (2008) Tabrizi, S; Craufurd, D; Durr, A; Fox, N; Frost, C; Hicks, S; Illmann, T; Johnson, H; Kennard, C; Landwehrmeyer, GB; Langbehn, D

Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS. (2010) Tur, C; Khaleeli, Z; Ciccarelli, O; Altmann, DR; Cercignani, M; Miller, DH; Thompson, AJ

Post-stroke case fatality within an incident population in rural Tanzania. (2011) Walker, Richard W; Jusabani, Ahmed; Aris, Eric; Gray, William K; Whiting, David; Kabadi, Gregory; Mugusi, Ferdinand; Swai, Mark; Alberti, George; Unwin, Nigel

Variant Creutzfeldt-Jakob disease: An epidemiological update in relation to geographically associated cases and history of vaccination. (2003) Ward, HJT; Everington, D; Cousens, S; Gill, N; Smith, PG; Will, R

Is there anything distinctive about epileptic deja vu? (2013) Warren-Gash, Charlotte; Zeman, Adam

Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study. (2006) Williams, DR; Watt, HC; Lees, AJ

Public

Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria. (2014) Brownlee, Wallace J; Swanton, Josephine K; Altmann, Daniel R; Ciccarelli, Olga; Miller, David H

Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records. (2013) Evans, Stephen JW; Douglas, Ian; Rawlins, Michael D; Wexler, Nancy S; Tabrizi, Sarah J; Smeeth, Liam

Visual dysfunction is a better predictor than retinal thickness for dementia in Parkinson's disease. (2023) Hannaway, Naomi; Zarkali, Angeliki; Leyland, Louise-Ann; Bremner, Fion; Nicholas, Jennifer M; Wagner, Siegfried K; Roig, Matthew; Keane, Pearse A; Toosy, Ahmed; Chataway, Jeremy; Weil, Rimona Sharon

Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia. (2020) Heller, Carolin; Foiani, Martha S; Moore, Katrina; Convery, Rhian; Bocchetta, Martina; Neason, Mollie; Cash, David M; Thomas, David; Greaves, Caroline V; Woollacott, Ione Oc; Shafei, Rachelle; Van Swieten, John C; Moreno, Fermin; Sanchez-Valle, Raquel; Borroni, Barbara; Laforce, Robert; Masellis, Mario; Tartaglia, Maria Carmela; Graff, Caroline; Galimberti, Daniela; Rowe, James B; Finger, Elizabeth; Synofzik, Matthis; Vandenberghe, Rik; de Mendonca, Alexandre; Tagliavini, Fabrizio; Santana, Isabel; Ducharme, Simon; Butler, Christopher R; Gerhard, Alex; Levin, Johannes; Danek, Adrian; Frisoni, Giovanni; Sorbi, Sandro; Otto, Markus; Heslegrave, Amanda J; Zetterberg, Henrik; Rohrer, Jonathan D; GENFI

Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study. (2014) Lu, Ching-Hua; Petzold, Axel; Topping, Jo; Allen, Kezia; Macdonald-Wallis, Corrie; Clarke, Jan; Pearce, Neil; Kuhle, Jens; Giovannoni, Gavin; Fratta, Pietro; Sidle, Katie; Fish, Mark; Orrell, Richard; Howard, Robin; Greensmith, Linda; Malaspina, Andrea

MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia. (2021) Manera, Ana L; Dadar, Mahsa; Van Swieten, John Cornelis; Borroni, Barbara; Sanchez-Valle, Raquel; Moreno, Fermin; Laforce, Robert; Graff, Caroline; Synofzik, Matthis; Galimberti, Daniela; Rowe, James Benedict; Masellis, Mario; Tartaglia, Maria Carmela; Finger, Elizabeth; Vandenberghe, Rik; de Mendonca, Alexandre; Tagliavini, Fabrizio; Santana, Isabel; Butler, Christopher R; Gerhard, Alex; Danek, Adrian; Levin, Johannes; Otto, Markus; Frisoni, Giovanni; Ghidoni, Roberta; Sorbi, Sandro; Rohrer, Jonathan Daniel; Ducharme, Simon; Collins, D Louis; FTLDNI investigators; GENFI Consortium

Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort. (2021) Peakman, Georgia; Russell, Lucy L; Convery, Rhian S; Nicholas, Jennifer M; Van Swieten, John C; Jiskoot, Lize C; Moreno, Fermin; Sanchez-Valle, Raquel; Laforce, Robert; Graff, Caroline; Masellis, Mario; Tartaglia, Maria Carmela; Rowe, James B; Borroni, Barbara; Finger, Elizabeth; Synofzik, Matthis; Galimberti, Daniela; Vandenberghe, Rik; de Mendonça, Alexandre; Butler, Chris R; Gerhard, Alex; Ducharme, Simon; Le Ber, Isabelle; Tagliavini, Fabrizio; Santana, Isabel; Pasquier, Florence; Levin, Johannes; Danek, Adrian; Otto, Markus; Sorbi, Sandro; Rohrer, Jonathan D; Genetic FTD Initiative (GENFI)

A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis. (2015) Sethi, Varun; Yousry, Tarek; Muhlert, Nils; Tozer, Daniel J; Altmann, Daniel; Ron, Maria; Wheeler-Kingshott, Claudia; Miller, David H; Chard, Declan T

Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease. (2012) Stout, Julie C; Jones, Rebecca; Labuschagne, Izelle; O'Regan, Alison M; Say, Miranda J; Dumas, Eve M; Queller, Sarah; Justo, Damian; Santos, Rachelle Dar; Coleman, Allison; Hart, Ellen P; Dürr, Alexandra; Leavitt, Blair R; Roos, Raymund A; Langbehn, Doug R; Tabrizi, Sarah J; Frost, Chris

Olfactory impairment in posterior cortical atrophy. (2013) Witoonpanich, Pirada; Cash, David M; Shakespeare, Timothy J; Yong, Keir XX; Nicholas, Jennifer M; Omar, Rohani; Crutch, Sebastian J; Rossor, Martin N; Warren, Jason D